FA
ASTH icon

Friess Associates’s Astrana Health ASTH Stock Holding History

Friess Associates’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-26,200
Closed -$1.93M – 122
2021
Q4 		$1.93M Sell
26,200
-29,353
-53% -$2.41M 0.75% 65
2021
Q3 		$5.06M Buy
55,553
+13,053
+31% +$1.11M 2.13% 10
2021
Q2 		$2.67M Buy
+42,500
New +$1.57M 1.01% 40

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Friess Associates's ASTH Position: Q1 2022 in Review

Friess Associates sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 26,200 shares — an estimated $1.93M sold.

Friess Associates first reported a position in ASTH in Q2 2021 and held it in 3 quarters. The position peaked at $5.06M in Q3 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Friess Associates reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Friess Associates sold 26,200 Astrana Health shares in Q1 2022, an estimated $1.93M.
  • Friess Associates first reported a position in Astrana Health in Q2 2021 and held it in 3 quarters.
  • Friess Associates's Astrana Health position peaked at $5.06M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Friess Associates's 13F filing for Q1 2022, filed 12 May 2022.